We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
The current NGENF market cap is 95.13M. The company's latest EPS is CAD -0.3463 and P/E is -6.44.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 31k | 0 | 0 | 0 | 0 |
| Operating Income | -1.36M | -8.4M | -9.93M | -11.14M | -21.98M |
| Net Income | -1.36M | -9.77M | -11.19M | -12.73M | -20.72M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 3.1M | 6.77M | 6.68M | 17.9M | 23.88M |
| Total Liabilities | 583k | 924k | 755k | 1.08M | 10.41M |
| Total Equity | 2.51M | 5.84M | 5.92M | 16.82M | 13.46M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -1.04M | -8.09M | -6.31M | -8.27M | -17.78M |
| Investing | -127k | N/A | -3k | -44k | -21k |
| Financing | 3.59M | 9.84M | 7.85M | 19.61M | 22.64M |
| Market Cap | 95.13M |
| Price to Earnings Ratio | -6.44 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.94 |
| Price to Book Ratio | 9.91 |
| Dividend Yield | - |
| Shares Outstanding | 59.83M |
| Average Volume (1 week) | 47.11k |
| Average Volume (1 Month) | 92.1k |
| 52 Week Change | 44.55% |
| 52 Week High | 2.99 |
| 52 Week Low | 1.10 |
| Spread (Intraday) | 0.24 (13.87%) |
| Company Name | NervGen Pharma Corporation (QX) |
| Address |
suite 2600, 595 burrard street vancouver, british columbia V7X 1L3 |
| Website | https://www.nervgenpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
